Waters Corporation reported first quarter 2023 sales of $685 million, a 1% decrease as reported but a 3% increase in constant currency. GAAP EPS decreased to $2.38, while non-GAAP EPS was $2.49, which includes an approximate 8% headwind due to unfavorable foreign exchange. The company's performance reflects a healthy two-year stacked growth rate of 9.4%.
First quarter sales declined 1% as reported but grew 3% in constant currency.
Growth in Asia and Europe was offset by weakness in China and the U.S.
Instrument revenues declined 3% in constant currency due to Pharma customer recalibration.
Recurring revenues grew high-single-digits in constant currency, supported by commercial initiatives.
The Company expects second quarter 2023 organic constant currency sales growth in the range of 1% to 3%. The Company expects second quarter 2023 non-GAAP EPS in the range of $2.52 to $2.62.
Visualization of income flow from segment revenue to net income